Home › Funds › Gagnon Advisors, LLC › TMCI
Gagnon Advisors, LLC position in TMCI
TREACE MED CONCEPTS INC · Health Care
Gagnon Advisors, LLC reported holding 1,534,034 shares of TMCI (TREACE MED CONCEPTS INC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 3.74% of its reported portfolio and ranking #14 among its reported holdings. Gagnon Advisors, LLC has disclosed TMCI holdings in 8 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Gagnon Advisors, LLC's TMCI position evolved
Gagnon Advisors, LLC first disclosed a stake in TMCI in Q3 2024 at 489,891 shares (US$2.8M). The position peaked in Q3 2026 at 1,534,034 shares, worth US$6.8M. Across 8 filings, Gagnon Advisors, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 1,534,034 shares valued at US$6.8M. Notable position changes include a 69% increase in Q2 2025 (shares rose 14% over the following quarter), a 58% increase in Q4 2025 (shares fell 45% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 489.89K | $2.84M | New |
| Q4 2024 | 489.89K | $3.64M | Hold |
| Q1 2025 | 489.89K | $4.11M | Hold |
| Q2 2025 | 830.27K | $4.88M | Add |
| Q3 2025 | 968.46K | $6.50M | Add |
| Q4 2025 | 1.53M | $3.76M | Add |
| Q2 2026 | 1.53M | $6.11M | New |
| Q3 2026 | 1.53M | $6.81M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TMCI and 13F data
TMCI (TREACE MED CONCEPTS INC) is a Health Care company. 19 other funds we track also report a position in TMCI — the largest reported positions include ARMISTICE CAPITAL, LLC (US$25.3M), GAGNON SECURITIES LLC (US$15.2M), WEBER CAPITAL MANAGEMENT LLC /ADV (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TMCI
- ARMISTICE CAPITAL, LLC 6.36M sh · $25.33M · Q2 2026
- GAGNON SECURITIES LLC 3.42M sh · $15.17M · Q3 2026
- WEBER CAPITAL MANAGEMENT LLC /ADV 589.62K sh · $2.62M · Q3 2026
More on Gagnon Advisors, LLC
FAQ
How long has Gagnon Advisors, LLC held TMCI?
Gagnon Advisors, LLC has disclosed TMCI holdings in 8 of the last 9 reported quarters, going back to Q3 2024.
What is Gagnon Advisors, LLC's current position in TMCI?
As of Q3 2026, Gagnon Advisors, LLC holds 1.53M shares of TMCI (TREACE MED CONCEPTS INC), valued at $6.81M, representing 3.74% of its reported portfolio and ranking #14.
Has Gagnon Advisors, LLC been buying or selling TMCI?
In the latest 13F filing (Q3 2026), Gagnon Advisors, LLC held unchanged its position in TMCI. The position peaked in Q3 2026 at 1.53M shares.
Which other funds hold TMCI?
Other major institutional holders of TMCI include ARMISTICE CAPITAL, LLC, GAGNON SECURITIES LLC, WEBER CAPITAL MANAGEMENT LLC /ADV, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.